Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cytrellis Biosystems, Inc.
The study subject population will consist to up to 30 subjects who meet the inclusion/exclusion criteria. All subjects will be monitored for a period of 6 months post last treatment.
An study results will be assessed on the following:
* POSAS - Patient Observer Scar Assessment
* ASAS - Acne Scar Severity Scale
* Subject Satisfaction Scale
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18 years of age or older
Fitzpatrick scale I-VI.
Any type of scar except for keloid scars
Able to provide written informed consent, understand and willing to comply with study related procedures and follow-ups.
You may not be if
Previous treatment of the scar tissue within last 6 months.
Silicone, fat, collagen or synthetic material in the treatment area.
History of keloid formation.
Active smokers (smoking more than ½ pack per day) or having quit smoking (½ pack per day) for less than 3 months.
Active, chronic, or recurrent infection.
Compromised immune system (e.g. diabetes).
Hypersensitivity to analgesic agents.
Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements.
Pregnant or breastfeeding.
Any issue that, at the discretion of the investigator, would contra-indicate the subject's participation.
Any medication that may cause bleeding such as anticoagulants.